BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coppola M, Villar-Hernández R, van Meijgaarden KE, Latorre I, Muriel Moreno B, Garcia-Garcia E, Franken KLMC, Prat C, Stojanovic Z, De Souza Galvão ML, Millet JP, Sabriá J, Sánchez-Montalva A, Noguera-Julian A, Geluk A, Domínguez J, Ottenhoff THM. Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups. Front Immunol 2020;11:103. [PMID: 32117257 DOI: 10.3389/fimmu.2020.00103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Khabibullina NF, Kutuzova DM, Burmistrova IA, Lyadova IV. The Biological and Clinical Aspects of a Latent Tuberculosis Infection. TropicalMed 2022;7:48. [DOI: 10.3390/tropicalmed7030048] [Reference Citation Analysis]
2 Alvarez AH. Revisiting tuberculosis screening: An insight to complementary diagnosis and prospective molecular approaches for the recognition of the dormant TB infection in human and cattle hosts. Microbiol Res 2021;252:126853. [PMID: 34536677 DOI: 10.1016/j.micres.2021.126853] [Reference Citation Analysis]
3 Coppola M, Jurion F, van den Eeden SJF, Tima HG, Franken KLMC, Geluk A, Romano M, Ottenhoff THM. In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination. NPJ Vaccines 2021;6:81. [PMID: 34083546 DOI: 10.1038/s41541-021-00343-2] [Reference Citation Analysis]
4 Castelhano MV, Martins Alves PC, Macedo VS, Arrym MP, Guimarães F, Panunto PC, Mazzola TN, Mauch RM, Vilela MMDS, Nolasco da Silva MT. Effective combined antiretroviral therapy provides partial immune recovery to mycobacterial antigens in vertically infected, BCG-vaccinated youth living with HIV. Tuberculosis 2022. [DOI: 10.1016/j.tube.2022.102170] [Reference Citation Analysis]
5 Lewinsohn DM, Lewinsohn DA. The Missing Link in Correlates of Protective Tuberculosis Immunity: Recognizing the Infected Cell. Front Immunol 2022;13:869057. [PMID: 35493495 DOI: 10.3389/fimmu.2022.869057] [Reference Citation Analysis]
6 Morgan J, Muskat K, Tippalagama R, Sette A, Burel J, Lindestam Arlehamn CS. Classical CD4 T cells as the cornerstone of antimycobacterial immunity. Immunol Rev 2021;301:10-29. [PMID: 33751597 DOI: 10.1111/imr.12963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Otero-Romero S, Sánchez-Montalvá A, Vidal-Jordana A. Assessing and mitigating risk of infection in patients with multiple sclerosis on disease modifying treatment. Expert Rev Clin Immunol 2021;17:285-300. [PMID: 33543657 DOI: 10.1080/1744666X.2021.1886924] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mao L, Xu L, Wang X, Du J, Sun Q, Shi Z, Wang J, Xing Y, Su Y, Xu Y, Qi Z, Xia L, Ma J, Zhang J. Use of DosR and Rpf antigens from Mycobacterium tuberculosis to screen for latent and relapse tuberculosis infection in a tuberculosis endemic community of Huainan City. Eur J Clin Microbiol Infect Dis 2022. [PMID: 35612766 DOI: 10.1007/s10096-022-04459-8] [Reference Citation Analysis]
9 Ivanyi J. Tuberculosis vaccination needs to avoid 'decoy' immune reactions. Tuberculosis (Edinb) 2021;126:102021. [PMID: 33254012 DOI: 10.1016/j.tube.2020.102021] [Reference Citation Analysis]
10 Adankwah E, Nausch N, Minadzi D, Abass MK, Franken KLMC, Ottenhoff THM, Mayatepek E, Phillips RO, Jacobsen M. Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis. J Infect 2021;82:245-52. [PMID: 33278400 DOI: 10.1016/j.jinf.2020.11.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]